Paragraph 6 Exceptions – human or veterinary medicines or immunomodulatory approaches
Exceptions to the activities described in paragraph 2 are the ownership, ownership of intellectual property or development of the matters set out in sub-paragraph (2) that employ synthetic biology at any stage of the development or production, unless the circumstances set out in sub-paragraph (3) apply.
The matters referred to in sub-paragraph (1) are—
human or veterinary medicines;
immunomodulatory approaches.
The circumstances referred to in sub-paragraph (1) are where the matter described in sub-paragraph (2)—
has a synthetic biology technology that could be employed or modified to produce, deliver or produce and deliver—
toxic chemicals to achieve an incapacitating or lethal effect on humans or animals;
materials restricted under Schedule 5 to the Anti-terrorism, Crime and Security Act 2001f1; or
uses substances or pathogens set out in Schedule 5 to the Anti-terrorism, Crime and Security Act 2001.
Annotations
Footnotes
- f1
-
Schedule 5 was amended by S.I. 2007/929 and 2012/1466.